- B2B
- Early StageStartup in initial stages
Biosortia Pharmaceuticals careers
Biosortia is unlocking the world's most valuable hidden chemistry
Biosortia Pharmaceuticals is unlocking the next frontier of chemistry for discovering new, groundbreaking drugs faster and more affordable by enabling unprecedented access to microbiome chemistry.
The company’s fully-developed technology delivers unlimited access to the hidden chemistry of microorganisms — significantly impacting future discoveries spanning numerous multibillion-dollar industries, including pharmaceutical, agriculture, consumer/cosmetic applications, and many more.
When it comes to their ability to produce bioactive small molecules for the development of groundbreaking new drugs, microorganisms remain unrivaled.
Chemistry obtained from culturable, or lab-grown, microorganisms have proven to be valuable therapeutic starting points — leading to more than 50% of approved drugs on the shelf.
Biosortia Pharmaceuticals is unlocking the next frontier of chemistry for discovering new, groundbreaking drugs faster and more affordable by enabling unprecedented access to microbiome chemistry.
The company’s fully-developed technology delivers unlimited access to the hidden chemistry of microorganisms — significantly impacting future discoveries spanning numerous multibillion-dollar industries, including pharmaceutical, agriculture, consumer/cosmetic applications, and many more.
When it comes to their ability to produce bioactive small molecules for the development of groundbreaking new drugs, microorganisms remain unrivaled.
Chemistry obtained from culturable, or lab-grown, microorganisms have proven to be valuable therapeutic starting points — leading to more than 50% of approved drugs on the shelf.
Biosortia Pharmaceuticals hasn't added any jobs yet
Get notified when Biosortia Pharmaceuticals posts new jobs.
Investor, Advisor, Serial Entrepreneur, Inventor, Adventurer, New Technology & Science Enthusiast, National Business Person of the Year & 5 Time Inc 500 list+
Valuation
$27M
Funded over
1 round
Latest round
Seed (Dec 2012)
Vantage Point Logistics • United States • 4 days ago
Ptc Therapeutics • United States • $123k – $154k • 5 days ago
Alexza Pharmaceuticals • Fremont • 1 week ago
Pfizer • New York City • $124k – $207k • 1 week ago
Emerald Therapeutics • Austin • 1 week ago






